Joseph Ciaffoni Archives - CDR – Chain Drug Review

Endo makes changes to executive team

December 27, 2016 by Chain Drug Review Blaise Coleman, Endo International, Joseph Ciaffoni, Matthew Davis, Patrick Barry, Paul Campanelli, Susan Hall Pharmacy, Supplier News

DUBLIN, Ireland — Endo International plc has announced executive changes in its U.S. branded drug and research-and-development units. Endo said Patrick Barry has been appointed as senior vice president of U.S. branded pharmaceuticals effective immediately and Matthew Davis as senior vice president of R&D for branded pharmaceuticals effective Jan. 3. Barry, who comes to Endo

Endo tabs Ciaffoni as U.S branded Rx president

August 12, 2016 by Chain Drug Review Brian Lortie, Endo International, Joseph Ciaffoni, Rajiv De Silva, U.S. branded pharmaceuticals Pharmacy, Supplier News

DUBLIN, Ireland — Joseph Ciaffoni has been named president of U.S. branded pharmaceuticals at Endo International plc. Endo said Ciaffoni is slated to start in the new post on Aug. 15. He joins the company from Biogen, where he was senior vice president of the global specialty medicines group. “I am thrilled to be joining